Hormone therapy in endometrial cancer survivors: time for a change
Authors:
- 28 September 2022
- journal article
- editorial
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 38 (10) , 795-796
Abstract
Endometrial cancer (EC) is one of the top 10 most frequently diagnosed cancers in women, with 417,000 new diagnoses made globally in 2020 [1]. North America and Europe are among the geographic area...Keywords
This publication has 14 references indexed in Scilit:
- Ovarian conservation for young women with early-stage, low-grade endometrial cancer: a 2-step schemaAmerican Journal of Obstetrics and Gynecology, 2021
- Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancerGynecologic Oncology, 2019
- Ovarian preservation improves overall survival in young patients with early-stage endometrial cancerOncotarget, 2017
- High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) DatabaseInternational Journal of Cancer, 2016
- 2016 IMS Recommendations on women’s midlife health and menopause hormone therapyClimacteric, 2016
- Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary TumorsPLOS ONE, 2015
- Survivors of gynecologic malignancies: impact of treatment on health and well-beingJournal of Cancer Survivorship, 2015
- Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: A meta-analysisEuropean Journal of Cancer, 2014
- Racial and Ethnic Differences in the Pathogenesis and Clinical Manifestations of Uterine LeiomyomaSeminars in Reproductive Medicine, 2013
- Adjuvant Hormonal Therapy for Stage I Endometrial CancerCurrent Oncology, 2008